PRODUCT FEATURES
- DERMALACZYN® has a randomized, placebo-controlled clinical trial (RCT), which demonstrates significant reduction in clinical symptoms of atopic dermatitis in children;
- The product has additional 3 RCTs published demonstrating improvements of other allergy symptoms;
- Stimulating the Th1 immune response (INF-γ) and reducing key mediators (IL-4 & IgE) of allergic response
- The Vitamin D included on its formulation helps modulates the immune response and also helps alleviating symptoms of atopic dermatitis;